Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of Fugan ointment in adults with mild to moderate subacute eczema
ChiCTR-IPR-17013054Phase 3Recruiting
- Sponsor
- Yueyang Hospital of Integrated Traditional Chinese and Western Medicine
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ZL-3101 in atopic dermatitis (AD) (3 arms), sponsored by Yueyang Hospital of Integrated Traditional Chinese and Western Medicine. Primary endpoint: Eczema Area and Severity Index score. Started Jun 2015; status: recruiting.
02
Drugs
ZL-3101
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on ChiCTR-IPR-17013054.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17013054.